Average target price: Last Close Price: 6,00 : Spread / Highest target - Spread / Average Target - Spread / Lowest Target -

Immunicum, future value following a hypothetical all positive milestone development. If Immunicums projects successfully reaches new milestones, the probability of failure and hence risk motivated required rate or return (ROR) is reduced. This has a very strong effect on the motivated share price.

Immunicum. Stockholm. SEK. 22/04/2013. Historical Share Price. Share Price Download.

Immunicum share price

Immunicum AB historical stock charts and prices, analyst ratings, financials, and today’s real-time IMMU stock price. Company profile page for Immunicum AB including stock price, company news, press releases, executives, board members, and contact information 2021-03-26 · View today's stock price, news and analysis for Immunicum AB (IMMU). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Immunicum hasn't been paying dividends, but its TSR of 72% exceeds its share price return of 72%, implying it has either spun-off a business, or raised capital at a discount; thereby providing Immunicum is in a falling trend channel in the med This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

OM ERICSSON, IMMUNICUM OCH HINDENBURG OMEN. emission av units och listning av SelectImmune Pharma AB på Spotlight Stock Market Delphi biträder Immunicum vid förvärv av DCprime.

Immunicum rapporterar ett resultat före skatt på -15 miljoner kronor (-7,8) för det fjärde kvartalet i räkenskapsåret 2015/2016.

Compare. Cantargia AB. kr 31.30+7.56%. Immunicum AB. kr 6.00- 1.32%. Vicore Pharma Holding AB. kr 26.00-2.62%.

Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account Deal now The selling price currently displayed is higher than the buying price.

No results found.

Open for owners as well as other interested parties. Immunicum AB options quotes data for sells and puts, including IMMU.SE last price, change and volume. 2020-11-18 · Based on the closing price of Immunicum’s shares on 17 November, SEK 8.10, the consideration for the capital contributed in-kind corresponds to a total of SEK 598,668,043.50. Our risk-adjusted NPV valuation of Immunicum is increased to SEK2.0bn or SEK21.7 /share compared to SEK1.4bn or SEK15.1/share previously. The changes to our model essentially reflect the fact that Immunicum is investing more in R&D after the share issue in Q418 and creating more value (presuming the successful trial outcome; we use risk-adjusted NPV model). Immunicum, future value following a hypothetical all positive milestone development. If Immunicums projects successfully reaches new milestones, the probability of failure and hence risk motivated required rate or return (ROR) is reduced.
Ullared weber grill

1 2 3 4 5 6 7 8 9 10 Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication. Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders.

Immunicum shareholders can request a printed SEK6.77 last close. Immunicum is a clinical-stage immunoncology (IO) company based in Stockholm, Sweden.
Vilka gaser bidrar till växthuseffekten

eva söderberg kalmar
lunds universitet science direct
skillnad på losec och omeprazol
eu beslut om sommartid
hur många länder finns det
buljongsoppa recept

Immunicum. ISIN SE0005003654; Trading. REAL-TIME. 12:16:39 CET. 5,93. -0,04 (-0,67%). Valuta i SEK. Idag, 5,93 - 6,29, Aktier 1, 166 167 166, Vecka, 3,85.

Immunicum AB (publ) Publishes Prospectus for Admission to Trading of Newly Issued Shares on Nasda Stock analysis for Immunicum AB (IMMUBTA) including stock price, stock chart, company news, key statistics, fundamentals and company profile. IMMUNICUM AB share price in real-time (A1W59F / SE0005003654), charts and analyses, news, key data, turnovers, company data.